DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Gainor JF, Varghese AM, Ou SH. et al.
ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer.
Clin Cancer Res 2013;
19 (15) 4273-4281
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.